Veristat

Veristat Acquires European Medical Writing Consultancy

Southborough, US - 12 June 12 2023 - Veristat, a scientific-minded global clinical research organization (CRO), has acquired Scinopsis, a European medical writing consultancy with a 17-year track record of delivering regulatory and medical communication documents of the highest quality to the biopharmaceutical industry. The acquisition strengthens Veristatís ability to meet growing client demand in...

Veristat Joins Decentralized Trials & Research Alliance (DTRA) to Improve the Patient Experience

SOUTHBOROUGH, MA - October 13, 2022 - Veristat, announced that it has joined an alliance of over 120 life sciences and healthcare organizations whose mission is to accelerate the broad adoption of patient-focused, decentralized clinical trials and research. The Decentralized Trials & Research Alliance (DTRA) unites industry stakeholders which include healthcare companies, regulators, patient groups,...

Veristat Launches Strategic Resourcing to Build Greater Flexibility in its Suite of Engagement Models

SOUTHBOROUGH, MA - 29 March 2022 - Veristat, a scientific-minded global clinical research organization (CRO), announced today the formalization of its Strategic Resourcing solution to offer clients the delivery of clinical development and regulatory expertise options fully tailored to their needs. Clients now have access to difficult-to-find experts dedicated to a specific requirement or function...

Veristat Expands its Expertise and Scale across Biopharma and Medtech

SOUTHBOROUGH, MA - 7 March 2022 - Veristat, a scientific-minded global clinical research organization (CRO), announced today the expansion and strengthening of its service capabilities by acquiring SFL (Solutions for Life Sciences). With headquarters in Basel, Switzerland and several European affiliates, SFL brings unique capabilities and a highly credentialed team to support a growing number...
Corporate Headquarters 134 Turnpike Road, Suite 200 Southborough, MA 01772 USA

+1 508-429-7340